Canine Bladder Cancer Clinic
The Purdue University College of Veterinary Medicine has a program aimed at helping dogs with urinary bladder cancer, especially dogs with the most common type of bladder cancer called transitional cell carcinoma, or TCC.
Roofus: A visit to the...
Canine Bladder Cancer Clinic
Roofus is a happy-go-lucky dog that does not know he has urinary bladder cancer. Roofus is part of a clinical trial in the Canine Bladder Cancer Clinic in the Purdue Comparative Oncology Program. His owner describes how Roofus appears to feel, and what has been involved for the dog in the treatment trial.
Purdue Comparative Oncology Program
The Purdue Comparative Oncology Program, also called PCOP, was formed with the mission to identify types of naturally-occuring cancer in pet animals that closely mimic those same types of cancer in people, and then to conduct studies that will improve the outlook for pet animals and humans with those cancers.
Wiley: A visit to the...
Purdue Comparative Oncology Program
Wiley is a dog with urinary bladder cancer who is participating in a treatment trial of folate-targeted therapy in the Purdue Comparative Oncology Program. Wiley's owner talks about the experience and what it is like to have a canine family member participate in a clinical trial at Purdue.
Purdue University Center for Cancer Research
Investigators working in cancer research in the College of Veterinary Medicine are part of a much larger cancer research community at Purdue University. The Purdue campus as a whole is an exciting and vibrant place to work in cancer research.
Basic Cancer Research Being Applied to Answer Clinical Questions
In addition to the work in the clinics diagnosing and treating cancer in pet dogs and cats, the Purdue Comparative Oncology team diligently works in a labratory setting to discover new ways to prevent and treat cancer.
Cystoscopy
There are several different medical conditions in dogs that can cause blood in the urine, straining to urinate, and masses in the bladder. These include infection and inflammatory processes, and multiple types of tumors.
Developing Nanoparticles to Treat Bladder Cancer
Nanoparticles are cancer agents that are designed to enter and kill cancer cells, while not harming normal cells. They are aimed at molecular targets on the surface of and inside cancer cells.
